TFG Asset Management’s Freeline Therapeutics Holdings plc American Depositary Shares FRLN Stock Holding History

TFG Asset Management’s Portfolio FRLN Stock Details FRLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-266,666	Closed	-$1.15M	–	36
2023 Q3	$1.15M	Hold	266,666	–	–	0.21%	33
2023 Q2	$688K	Sell	266,666 -1	-0%	-$4	0.09%	40
2023 Q1	$1.82M	Hold	266,667	–	–	0.24%	36
2022 Q4	$1.9M	Hold	266,667	–	–	0.27%	35
2022 Q3	$2.8M	Buy	266,667 +15,966	+6%	+$208K	0.34%	44
2022 Q2	$3.27M	Buy	250,701 +4,034	+2%	+$51.9K	0.22%	89
2022 Q1	$4.14M	Buy	246,667 +145,143	+143%	+$2.69M	0.19%	99
2021 Q4	$3.02M	Buy	101,524 +28,191	+38%	+$1.15M	0.18%	104
2021 Q3	$3.75M	Buy	73,333 +23,333	+47%	+$1.66M	0.23%	81
2021 Q2	$6.11M	Hold	50,000	–	–	0.33%	56
2021 Q1	$9.22M	Hold	50,000	–	–	0.66%	27
2020 Q4	$13.7M	Buy	50,000 +1,333	+3%	+$335K	0.92%	20
2020 Q3	$11.4M	Buy	+48,667	New	+$12.2M	1.05%	24

Other funds holding FRLN

Syncona Portfolio St Peter Port, Guernsey $25.7M AUM 13.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BOCH

Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PCM

PenderFund Capital Management Vancouver, British Columbia, Canada $639M AUM 31.05% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

HCA

Harbor Capital Advisors Chicago, Illinois $1.23B AUM 30.56% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

TFG Asset Management's FRLN Position: Q4 2023 in Review

TFG Asset Management sold out of Freeline Therapeutics Holdings plc American Depositary Shares (FRLN) in Q4 2023, closing a stake of 266,666 shares — an estimated $1.15M sold.

TFG Asset Management first reported a position in FRLN in Q3 2020 and held it in 13 quarters. The position peaked at $13.7M in Q4 2020. 15 funds tracked by Wall St. Rank hold FRLN as of Q4 2023.

TFG Asset Management reported no remaining Freeline Therapeutics Holdings plc American Depositary Shares position as of Q4 2023 after selling out during the quarter.
TFG Asset Management sold 266,666 Freeline Therapeutics Holdings plc American Depositary Shares shares in Q4 2023, an estimated $1.15M.
TFG Asset Management first reported a position in Freeline Therapeutics Holdings plc American Depositary Shares in Q3 2020 and held it in 13 quarters.
TFG Asset Management's Freeline Therapeutics Holdings plc American Depositary Shares position peaked at $13.7M in Q4 2020.
15 funds tracked by Wall St. Rank held Freeline Therapeutics Holdings plc American Depositary Shares as of Q4 2023.

Based on TFG Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.